Industry association · Poland · EU Transparency Register TR ID 707197749527-51not in register snapshot
This register number is the organization’s own declaration on its submission. It is not in the 15 Oct 2026 snapshot of the EU Transparency Register, so we neither link to it nor use it to identify this organization.
Counts here are a floor, never a total: they cover the 665 consultation files tracked so far (57,800 submissions, mostly 2021–26), so an organization's real filing history is larger, not smaller.
Track Związek in PolicySpeak: request access →
Work at Związek Pracodawców Innowacyjnych Firm Farmaceutycznych INFARMA? so we know who speaks for it.
Związek Pracodawców Innowacyjnych Firm Farmaceutycznych INFARMA filed 2 positions between 27 Apr 2021 and 7 Nov 2023, across 1 of the 665 legislative files tracked here, attaching a full position paper 2 times.
The revision of the EU pharmaceutical legislation is key to shaping market conditions for the pharmaceutical industry and, above all, to improve patients’ access to innovative medicines. The final form of these rules will depend on the competitiveness and safety of Europe’s medicines, the access of Europeans to state-of-the-art medicines technologies and the economic development of European Union countries.
Filed in Polish · English published by the European Commission
The Association of Innovative Pharmaceutical Employers INFARMA represents 25 pharmaceutical, R & D and innovative medicines companies. The mission of INFARMA member companies is to ensure accessible treatments for all Polish patients and to improve their treatment standards.
Filed in Polish · English published by the European Commission
Looking for an argument rather than an organization? Search every submission for a phrase and see everyone who used it.
Put Związek Pracodawców Innowacyjnych Firm Farmaceutycznych INFARMA next to another organization. Same files, same register facts, side by side. Compare →
Everything on this page comes from Związek Pracodawców Innowacyjnych Firm Farmaceutycznych INFARMA’s own submissions to the European Commission. We have added nothing and interpreted nothing. If something is wrong or out of date, email info@policyspeak.com and we will correct it. If you are an individual named in a record, our privacy policy sets out your rights to correction, objection and removal.
Quotes are verbatim from submissions published by the European Commission, trimmed to their opening passage and never summarized by a model. Organizations only, never individuals. Reused under Commission Decision 2011/833/EU; the European Commission is not liable for this reuse.